Variant report
Variant | esv3448966 |
---|---|
Chromosome Location | chr6:26956873-26960071 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs201586386 | chr6:26956942-26956943 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs59152492 | chr6:26956952-26956953 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs576882166 | chr6:26957073-26957074 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs566137731 | chr6:26957216-26957217 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs539569508 | chr6:26957224-26957225 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs556488766 | chr6:26957276-26957277 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs193130951 | chr6:26957289-26957290 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs185284278 | chr6:26957389-26957390 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs554705244 | chr6:26957398-26957399 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs148720851 | chr6:26957431-26957432 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs111355542 | chr6:26957435-26957436 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs3999242 | chr6:26957445-26957446 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs576223369 | chr6:26957510-26957511 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs561072784 | chr6:26957525-26957526 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs191649411 | chr6:26957544-26957545 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs3999243 | chr6:26957586-26957587 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs540388244 | chr6:26957587-26957588 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs560392533 | chr6:26957610-26957611 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs532217469 | chr6:26957643-26957644 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs545928054 | chr6:26957670-26957671 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs562483458 | chr6:26957725-26957726 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs188180583 | chr6:26957773-26957774 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs180930806 | chr6:26957792-26957793 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs3999248 | chr6:26957805-26957806 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
25 | rs527984155 | chr6:26957806-26957807 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs184456991 | chr6:26957817-26957818 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs3999250 | chr6:26957915-26957916 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs570730040 | chr6:26957960-26957961 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs190623279 | chr6:26957965-26957966 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs182291835 | chr6:26957968-26957969 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs570027601 | chr6:26957989-26957990 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs535518417 | chr6:26958102-26958103 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs3999253 | chr6:26958120-26958121 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs577481509 | chr6:26958169-26958170 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs555738944 | chr6:26958172-26958173 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs9366676 | chr6:26958180-26958181 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs540554222 | chr6:26958187-26958188 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs559087363 | chr6:26958308-26958309 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs553973256 | chr6:26958314-26958315 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs577141437 | chr6:26958315-26958316 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs574431685 | chr6:26958348-26958349 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs545913305 | chr6:26958384-26958385 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs113534039 | chr6:26958422-26958423 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs541936019 | chr6:26958481-26958482 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs9467936 | chr6:26958528-26958529 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
46 | rs190503934 | chr6:26958667-26958668 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs561748840 | chr6:26958761-26958762 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs12663161 | chr6:26958784-26958785 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
49 | rs147609970 | chr6:26958790-26958791 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs181089497 | chr6:26958791-26958792 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Leukemia | 21518781 | CNVD |
Cancer | 21637783 | CNVD |
Facial dysmorphism | 22105932 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Bladder cancer | 19088036 | CNVD |
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Biliary cancer | 19435499 | CNVD |
Malaria | 21533027 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
Lung cancer | 18438408 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Gastric cancer | 16891809 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Autism | 21448237 | CNVD |
Cancer | 20164919 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 22844521 | CNVD |
HIV/AIDS | 22844521 | CNVD |
Ovarian cancer | 22844521 | CNVD |
Prostate cancer | 22844521 | CNVD |
Psoriasis | 22844521 | CNVD |
Rheumatoid arthritis | 22844521 | CNVD |
Sclerosis systemic | 22844521 | CNVD |
Systemic lupus erythematosus | 22844521 | CNVD |
Breast cancer | 22522925 | CNVD |
Breast cancer | 21552322 | CNVD |
Immune disease | 21076436 | CNVD |
Autoimmune disease | 19135723 | CNVD |
Systemic lupus erythematosus | 17953491 | CNVD |
Recurrent Infections | 22737222 | CNVD |
Systemic lupus erythematosus | 21904924 | CNVD |
Ependymoma | 19289631 | CNVD |
Gestational infection | 22844521 | CNVD |
Head circumference | 22844521 | CNVD |
Infertility | 22844521 | CNVD |
Recurrent birth weight diabetes | 22844521 | CNVD |
Obesity | 22844521 | CNVD |
Recurrent pregnancy loss | 22844521 | CNVD |
Intellectual disability | 21811512 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Nasopharyngeal cancer | 22815911 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 17133270 | CNVD |
Autism | 22495311 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Cancer | 16790693 | CNVD |
Breast cancer | 22032731 | CNVD |
Cervical cancer | 21062161 | CNVD |
Breast cancer | 21785460 | CNVD |
Retinoblastoma | 16790693 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Cancer | 21183584 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Williams-beuren syndrome | 16971481 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Gastric cancer | 17908304 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 16397240 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 21509527 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Breast cancer | 21364760 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:26953600-26966000 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |